The mammalian collagenases are a subgroup of the matrix metalloproteinases (MMPs) that are uniquely able to cleave triple helical fibrillar collagens. Collagen breakdown is an essential part of extracellular matrix turnover in key physiological processes including morphogenesis and wound healing, however, unregulated collagenolysis is linked to important diseases such as arthritis and cancer.
The matrix metalloproteinases (MMPs) ¶ are a family of zinc endopeptidases that share homologous catalytic domains. These enzymes catalyze the cleavage the protein components of the extracellular matrix and play a pivotal role in connective tissue remodeling during development, wound healing and other physiological processes (1) . There are a total of 24 MMPs in humans that have broad and overlapping specificities. The collagenases, a subgroup of MMPs that cleave collagens type I, II and III, include MMP-1 (fibroblast collagenase), MMP-8 (neutrophil collagenase) and MMP-13 (collagenase-3) (2, 3, 4) . MMP-1 is considered a prototype for all interstitial collagenases and plays an important role in the turnover of collagen fibrils in the matrix. Much evidence indicates that collagenolysis is an important event in diverse physiologic processes such as development, tissue morphogenesis, and wound repair (5) while unregulated collagen breakdown has been implicated in a variety of human diseases including cancer, rheumatoid arthritis, pulmonary emphysema and fibrotic disorders (6) . Therefore knowledge of the structural basis of collagenase action and its regulation is crucial for understanding the molecular basis of these diseases and opening new therapeutic avenues.
MMPs are initially synthesized as inactive precursors (pro-MMPs) and the levels of MMP activity in tissues are closely regulated at the levels of gene expression, pro-MMP activation and inhibition of the active enzymes. The principal endogenous inhibitors of active MMP in tissues are four tissue inhibitors of metalloproteinases (TIMP-1 to TIMP-4). These two-domain proteins are 40-50% identical in sequence (7) . Their N-terminal domains have about 120 amino acids while the C-domains contain about 65 residues; in mammalian TIMPs, each domain is stabilized by three disulfide crosslinks (8) . The N-terminal domains (designated N-TIMPs) can fold independently and carry the full inhibitory activity towards their target MMPs (9, 10) .
TIMPs form tight non-covalent 1:1 inhibitory complexes with MMPs albeit with relatively low selectivity (10) . An exception to this is TIMP-1, which is a weak inhibitor of some membrane-type MMPs. Crystal structures have been determined of two inhibitory MMP•TIMP complexes: the catalytic domain of MMP-3 (MMP-3cd) in complex with the fulllength TIMP-1 (PDB code: 1UEA; 11), and the complex of MT1-MMPcd with TIMP-2 (PDB code: 1BQQ; 12). In addition, a structure has been determined for the complex of pro-MMP-2 with the full-length TIMP-2 (PDB code: 1GXD; 13) which exemplifies a distinct type of noninhibitory complex stabilized by interactions between the C-terminal domain of TIMP and the non-catalytic hemopexin domains of pro-MMP.
The previously determined structures show that the N-terminal inhibitory domains of TIMPs have the widely distributed OB (oligonucleotide-binding) fold. In the inhibitory complexes, this domain makes most of contacts with the protease. The core of the interaction site is a continuous ridge stabilized by a disulfide bond between Cys1 and Cys70, that links the Nterminal four residues (Cys 1 -Thr-Cys-Val 4 ) with residues Met 66 -Glu-Ser-Val-Cys 70 . Cys 1 interacts bidentately with the catalytic zinc through the Nterminal α-amino group and carbonyl group, displacing the water molecule that is needed for peptide bond hydrolysis, while residue 2 (Thr 2 in TIMP-1) interacts with the so-called S1′ specificity pocket of the MMP, a region that has a dominant role in enzyme specificity. In addition, the structures also show that the loops of the N-terminal domain of TIMP-1 between β-strands A and B and between strands E and F, also facilitate interactions of the inhibitor with the protease. Mutational analyses of residues implicated in binding have shown that changes in the interaction site in TIMPs can significantly change its relative affinity for different MMPs, raising the possibility of generating TIMP variants that are selective inhibitors of diseaserelated MMPs that could open a novel approach to disease treatment (14, 15) .
The structures of different TIMP•MMP complexes can provide information about differences in interaction interfaces that are crucial for the rational design of selective TIMP variants. For this reason we have conducted an X-ray crystallographic analysis of the complex formed between N-TIMP-1 and the catalytic domain of MMP-1 (MMP-1cd). The crystal structure provides new insights into features that influence the affinity of MMP-1 and thus helps provide a crucial platform for further engineering of MMP-selective TIMPs and small molecule inhibitors.
EXPERIMENTAL PROCEDURES
Cloning, protein expression and protein purification -Human N-TIMP-1 was expressed in E. coli (BL21 DE3) cells, partially purified and folded as described previously (16) , with the exception that the protein was extracted from inclusion bodies and initially purified by gel filtration in 6M guanidine HCl rather than 8M urea. After partial purification of the folded protein by cation exchange chromatography with CM-cellulose, further purification was performed by medium pressure cation exchange chromatography using a Bio-Rad Biologic DuoFlow chromatography system to separate active and inactive forms of the protein (17) . After dialysis against 20 mM Bis-Tris HCl pH 5.5, the N-TIMP-1 was applied to a Mono S HR (5/5) column (Amersham Biosciences) that had been previously equilibrated with the same buffer. Elution was performed with a linear gradient from 0 to 0.5 M NaCl over 60 min at a flow rate of 1 ml/min and the effluent was monitored by absorbance at 280 nm. Two similarly sized slightly overlapping peaks were collected manually of which the second contained the MMP-inhibitory activity.
The vector for bacterial expression of the catalytic domain of MMP-1 (pET3a: MMP-1 cd) was kindly provided by Dr. H. Nagase. Protein expression and isolation of inclusion bodies was carried out as for N-TIMP-1. Recombinant protein was extracted from inclusion bodies with 8 M urea containing 20 mM Tris HCl pH 8.5 containing 10 mM DTT and insoluble material was removed by centrifugation at 12000 rpm for 30 min at 4°C. The supernatant was applied to a column (1.5 x 10 cm) of MacroPrep 50Q anion exchange resin that had been equilibrated with 20 mM Tris HCl buffer, pH 8.0 containing 8 M urea that was subsequently washed with the same buffer at a flow rate of 1.5 ml/min. The protein was eluted with a linear gradient from 0 to 0.5 M NaCl in equilibration buffer at the same flow rate and collected in 4.5 ml fractions. Fractions containing MMP-1cd were identified by SDS-PAGE and pooled. For folding, the denatured protein was dialyzed twice (16 h each) against 50 mM Tris HCl pH 8.0 containing 250 mM NaCl, 20 mM CaCl 2 and 50 µM ZnCl 2 at 4 °C. The solution was centrifuged at 12,000 rpm at 4 °C for 30 min to remove precipitate and the supernatant was purified by gel filtration with a column (2.5 x 35 cm) of Superdex-75 that was equilibrated and eluted with 50 mM TrisHCl pH 7.5 containing 150 mM NaCl and 20 mM CaCl 2 at a flow rate of 1.5 ml/min.
Preparation of N-TIMP-1/MMP-1cd complex -
Samples of N-TIMP-1 (3ml: 330 nmol) and MMP-1cd (25 ml: 230 nmol) in TNC buffer (50 mM Tris HCl buffer pH 7.5 containing 150 mM NaCl, and 10 mM CaCl 2 ), were mixed and incubated overnight at room temperature to ensure complex formation. The solution was concentrated to about 12 ml and the complex was purified by gel filtration with a column of Superdex-75 (3.5 x 40 cm) equilibrated and eluted with TNC buffer at a flow rate of 1.5ml/min. Fractions of 6 ml were collected and protein detected by absorbance at 280 nm. The elution profile (not shown) consisted of a major peak followed by a minor peak; SDS-PAGE of the major peak (complex) gave bands with apparent molecular masses of 14.5 and 19 kDa, corresponding to N-TIMP-1 and MMP-1cd, while the minor peak contained only N-TIMP-1.
Crystallization, X-ray diffraction data collection and processing -Crystals for the N-TIMP-1•MMP-1cd complex were grown at 16°C by the hanging drop vapor diffusion technique with 10% PEG 8000, 8% ethylene glycol and 0.1M HEPES (pH 7.5) as the reservoir solution. A full dataset to 2.54 Å resolution was collected on station PX 9.6 of the SRS, Daresbury (UK), at 100K from a single crystal. Data processing was performed with the HKL package (18) in the Ccentered monoclinic space group, C2. Data reduction carried out using the program, TRUNCATE, of the CCP4 suite (19) estimated an overall B-factor of 59.9 Å 2 from the Wilson plot.
Structure determination -Cell content analysis suggested the possibility of 2-3 complexes in the asymmetric unit and the native Patterson revealed a strong pseudo-translation at 1/3,0,0. The structure was solved by molecular replacement method using the program AMoRe (20). The catalytic domain of MMP-1 (PDB code: 1CGL; 21) and the N-terminal domain of TIMP-1 (PDB code: 1UEA; 11) were used as search models for the individual components of the complex. The command script for AMoRe was edited to include the NCS translation vector [0.33 0.00 0.00]. Once the three MMP-1cd molecules were located and their position in the asymmetric unit defined, the N-TIMP-1 molecules were located one by one. Structures for the three MMP-1cd molecules and the three N-TIMP-1 molecules were built and ensured that there were no symmetry-related clashes using the program COOT (22).
Structure
refinement -Crystallographic refinement was carried out using the program CNS (23) at 2.54Å resolution against 91.2% of the measured data. A test set of random reflections of 2.7% was excluded from the full data set for cross-validation purposes (24) by calculating the free R-factor (R free ) to monitor refinement trend. Initial round of refinement with the three complexes found by AMoRe (20) resulted in an R cryst of 37.6% and an R free of 43.0%. Few cycles of refinement [energy minimization, simulated annealing and individual temperature factor (B-factor) refinement] using NCS restraints in CNS (23) and model building with reference to 2F o -F c and F o -F c maps using the program COOT (22) progressively improved the phases. In the later stages of refinement, REFMAC (25) was used to incorporate TLS (26) thermal refinement. Each molecule within the asymmetric unit was defined as a TLS tensor group for the purpose of refinement. Refinement proceeded in [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] cycles of TLS refinement with atomic residual isotropic B-factors set at 45 Å 2 , followed by 15 cycles of individual atomic restrained refinement. Water molecules with peaks greater than 3σ in the F o -F c maps and those within hydrogen bonding distances from appropriate atoms were incorporated into the structure. The final refined structure at 2.54 Å resolution has an R cryst of 24.8% and an R free of 27.5% (Table 1) .
RESULTS AND DISCUSSION
The structure of the N-TIMP-1•MMP1cd complex (Figure 1 ) was determined at 2.54 Å resolution. Details of the data processing and refinement statistics are given in Table 1 . The crystallographic asymmetric unit contains three copies of the complex. All the three complexes in the asymmetric unit are identical in their orientation and are translationally related to each other, along the x-axis, by the vector: 0.33, 0, 0. The MMP components of these complexes are designated A, B and C and the cognate N-TIMP components D, E and F, respectively. Residues 49-57 in all the three N-TIMP-1 molecules could not be positioned unambiguously because of the lack of electron density and were therefore modeled as glycines. The other residues modeled as glycine or alanine includes 41, 78, 91, 114 and 118 of N-TIMP-1. The disordered residues are distant from the binding interface and consequently, do not affect our analysis of the interactions between the two components of the complex. The refined model includes 854 protein residues, 42 water molecules, 6 zinc ions and 9 calcium ions. Analysis with PROCHECK (27) indicates that the ϕ-ψ conformational angles are within the limits expected for a structure at this resolution with no residues in the disallowed region of the Ramachandran plot (99.3% residues in the core region).
Overall structure of the complex -The inhibitory domain of TIMP-1 has a characteristic OB-fold architecture consisting of a five-stranded β-sheet of Greek key topology and two or three The catalytic domain of MMP-1 also exhibits the typical extended ellipsoid shape where the active-site cleft anchoring the catalytic zinc bifurcates the upper sub-domain from the lower sub-domain. Apart from the active-site zinc, the domain also contains a structural zinc ion and three calcium ions that are required for stability and structure. All the analyses reported here have been carried out using . In all these superpositions it was observed that the catalytic domains of the different complexes aligned quite well whereas the TIMP components exhibited most of the differences.
Characteristics of the interface -N-TIMP-1 recognises three segments of the catalytic domain of MMP-1: residues 178-186, 218-228 and 238-240 ( Figure 3) . Formation of the complex buries a total of about 1500 Å 2 of the solvent-accessible area of the two proteins, about 60% of the interface being contributed by MMP-1cd. In all, 18 residues from N-TIMP-1 and 22 residues from MMP-1cd participate in the interface, forming 87 van der Waals contacts (Table 2) and 12 H-bonds (Table 3 ). The total number of van der Waals contacts observed at the interface is slightly lower than those for the TIMP-1/MMP-3 and TIMP-2/MT1-MMP complexes although the total number of direct hydrogen-bonding interactions at the interface in the three complexes remains the same. Complex A shares 10 hydrogen bonds with the TIMP-1•MMP-3cd complex and 9 with the TIMP-2•MT1-MMPcd complex; 7 hydrogen bonds are conserved between all three complexes. The majority of all intermolecular contacts is made by the five N-terminal residues (Cys of the protease. This contrasts with the multiple contacts observed in the TIMP-1/MMP-3cd complex (Table 2) , and suggests that interactions involving the A-B loop do not make a significant contribution to the free energy of interaction with MMP-1. There is only one water-mediated interaction observed at the interface of Complex A. This water molecule, W3, bridges an interaction between Ser 68 of the inhibitor and Gln 186 of the enzyme. However, this interaction is not present in the other two complexes in the asymmetric unit.
Structural basis for the differences in inhibitory specificity of TIMP-1 -The four mammalian TIMPs are generally similar in structure and action but differ from each other by more than 50% in sequence; this level of sequence divergence might suggest they have specialized functional properties and play distinct biological roles in vivo (31, 32) . Apart from its rather weak interactions with some membrane-type MMPs and MMP-19, TIMP-1, like the other three TIMPs, is a broad-spectrum MMP inhibitor and forms tight 1:1 inhibitory complexes with virtually all MMPs (31) .
The ability of TIMP-1 to recognize MMPs with differing substrate specificity and active site structures could be achieved by exploiting main-chain interactions with the cognate MMP or by relying on few but conserved side-chain interactions. The mechanism of inhibition became apparent when the crystal structure of TIMP-1•MMP-3cd complex (11) revealed the importance of residues around the disulfide bond between Cys1 and Cys70 in TIMP-1 that occupied the entire length of the active-site cleft of MMP-3. The present structure of the complex of the N-TIMP-1 and MMP-1cd reveals variability in the molecular basis of MMP recognition and shows that even the conserved interface residues on TIMP-1 form largely different interactions with the cognate MMP.
One difference with respect to the earlier TIMP-1 complex is the smaller size of the buried surface (1500 vs 2000 Å 2 ). However, if conformational changes that occur on complex formation are taken into account, the buried surface area in the N-TIMP-1/MMP-3 complex reduces to 1400 Å 2 (17) . The current complex has only four amino acids less than the previous complex at the interface, associated with the lack of interactions from the TIMP-1 A-B loop but conformational changes in the N-terminal region of the protease are not observed in the MMP-1 complex (all the comparative analyses reported here relate only to the N-terminal domain of the TIMP-1 and not the full-length TIMP-1 from the TIMP-1•MMP-3cd complex). Of the 12 hydrogen-bonding interactions between the inhibitor and the protease, 10 are equivalent between the two complexes (Table 3) . Beyond these hydrogen bonds, the two complexes also share a number of van der Waals contacts. What makes the interactions more distinct in the two structures is the difference in the chemical character of the atoms participating in the interactions at the interface (Table 4 ). The N-TIMP-1•MMP-1cd interface is about 77% nonpolar, 11% uncharged polar and 12% charged polar. This distribution is conspicuously more non-polar than that in the TIMP-1•MMP-3cd complex, (which is about 70% non-polar, 23% uncharged polar and 11% charged polar) and the proportion of charged residues is higher. The binding surface on the TIMP-1 molecule in the two complexes with the different MMPs is characteristically different in relation to the role of the A-B loop. Similarly, the chemical characters of the atoms involved from the MMP counterparts in the two complexes also differ. This suggests that although the overall docking of the MMPs in the two TIMP-1 complexes analyzed so far is similar, the specific interactions at the interface are quite distinct and the versatility of TIMP-1 to inhibit both MMP-1 and MMP-3 reflects its ability to interact with both conserved features of the active sites and features unique to each of the two MMPs. Although multiple substitutions are required to produce N-TIMP-1 variants with high selectivity for MMPs (9, 14, 15, 33) , substitutions for Thr 2 of N-TIMP-1 show that this residue has a dominant influence on the free energy of binding selectivity for MMPs. Consequently, this residue, which is located centrally in the MMPbinding ridge and interacts with the S1' specificity pocket of MMPs has been designated as a hot-spot in the interaction interface (14, 15) .
Correlation of structural data with results from mutagenesis experiments -
To understand the effects of Thr 2 substitutions, we modeled selected mutants of N-TIMP-1 in the present N-TIMP-1•MMP-1cd complex and the previously reported TIMP-1•MMP-3cd complex. Each complex was subjected to energy minimization using CNS (23) to ensure that the mutated structure was devoid of steric clashes. Analyses of the effects of some mutations on N-TIMP-1/MMP contacts are summarized in Table 5 .
The N-TIMP-1 mutant with a T2G substitution, which effectively eliminates the side chain, is greatly reduced in affinity for most MMPs, including MMP-1 and MMP-3, indicating the importance of interactions with the MMP-1 S1′ pocket. In the model containing this mutant in a complex with MMP-1, there are 33 fewer van der Waals contacts and 11 fewer H-bonding interactions at the interface. Residue 2 alone has 9 fewer interactions as compared to the complex containing wild-type N-TIMP-1. Interactions of other N-TIMP-1 residues, particularly Pro 5 , Met 66 and Cys 99 , at the periphery of the interaction site, increase in the model, but these are expected to make weaker contributions to the free energy of binding. In the case of the complex of the T2G mutant with MMP-3, fewer interactions from residue 2 are lost (9, as opposed to 10) and the higher affinity for MMP-3 relative to MMP-1 for the T2G mutant suggests that the interactions of the side chain of residue 2 are less important for binding MMP-3 than MMP-1.
An analysis of the effects of side chain chemistry on binding to different MMPs for 15 different substitutions for residue 2 of N-TIMP-1 shows that hydrophobicity favors binding to MMP-1 relative to MMP-3, while increased size is unfavorable for MMP-1 but favorable for MMP-3. Side chain charge, particularly positive charge, disfavors binding to MMP-1 relative to other MMPs including MMP-3. The Arg 2 mutant shows the greatest selectivity against MMP-1 relative to MMP-2 and MMP-3 (14) . This is consistent with the structure of the S1′ pocket of MMP-1. Modeled complexes for this mutant, show 2 additional hydrogen-bonding interactions and 27 more van der Waals contacts in the MMP-3 complex as compared with the MMP-1 complex. Because the S1′ pocket of MMP-1 is narrower and more shallow than in other MMPs (34) it is difficult to accommodate the larger arginine side-chain without structural rearrangement. Furthermore, the presence of Arg 214 in MMP-1 S1′ pocket in place of leucine at the equivalent site in MMP-3 would be expected to result in charge repulsion between the Arg 2 of N-TIMP-1 and Arg 214 of MMP-1. The modeled N-TIMP-1(T2R)•MMP-1cd complex shows a rearrangement in which the side-chain of Arg 214 projects away from the S1′ pocket instead of inwards. The rearrangement of surrounding residues is reflected in an r.m.s.d. of ~ 1.3 Å between the wild-type and modeled complex containing the N-TIMP-1 mutant.
Substitutions of negatively charged residues for Thr 2 are unfavorable for binding to MMPs. MMP-1, however, is intolerant to both negative and positive charges at this site (15) . To attempt to understand this, we have compared the interactions at the interface in models of the isosteric pairs, T2D/T2N and T2E/T2Q, in complexes with MMP-1 and MMP-3. This reveals that there are one-third fewer total van der Waals for all of these mutants in the MMP-1 complex as compared with the wild-type N-TIMP-1 complex. Similarly, the slightly larger number of van der Waals contacts for the T2N/T2Q mutants relative to the T2D/T2E mutants in the N-TIMP-1•MMP-3cd complex correlates well with the results of activity measurements (14) . Substitution of different non-polar residues at position 2 also affects the binding of N-TIMP-1 to MMPs. The preference for the smaller size and non-polarity of the sidechain at position 2 for MMP-1 binding is reflected in the selectivity of the T2V mutation for MMP-1. Modeling indicates that valine at this position results in 7 more van der Waals contacts in the MMP-1 complex compared to the wild type protein but 25 fewer in the MMP-3 complex, explaining the preference for MMP-1 relative to MMP-3.
The structures of TIMP/MMP complexes provide a basis for designing TIMP variants with increased selectivity for different MMPs. Such variants are potentially useful for investigating the roles of different MMPs in biological and pathological processes and may provide a novel route for therapy in diseases associated with excess MMP activities. The present study shows that although TIMP-1 has a similar affinity for MMP-1 and MMP-3, there are striking differences in the chemistry and structures of the interaction sites. This suggests that the elucidation of the structures of more MMP-TIMP complexes would be worthwhile. (2) , His183, His218 (4) , Glu219 (6) , His222 (2) , His228 [16] Val163, Ala165 (2) , His166, His201, Glu202 (2) , His205 (2) , His211 (4) , Pro221 [14] Thr2 Asn180 (3) , Leu181, Val215 (2) , His218, Glu219 (2) , Pro238 (2) , Tyr240 (2) [13]
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